Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: January 2015
-
By Andrew Williams — On January 13, 2015, the Patent Trial and Appeal Board ("PTAB" or "Board") denied institution of four covered business method ("CBM") patent review petitions filed by Par Pharmaceutical, Inc. ("Par"), Roxane Laboratories, Inc. ("Roxane"), and Amneal Pharmaceutical, LLC ("Amneal") (together, "petitioners") against patents owned by Jazz Pharmaceutical, Inc. All of these…
-
By Andrew Williams — Last week, at their January 7, 2015 meeting, the FDA's Oncologic Drugs Advisory Committee ("ODAC") recommended the approval of Sandoz's biosimilar filgrastim application to market a version of Amgen's NEUPOGEN® biologic drug. As we previously reported, the Sandoz application is believed to be the first application accepted under the new biosimilar…
-
By Donald Zuhn — Last month, in Promega Corp. v. Life Technologies Corp., the Federal Circuit determined that U.S. Patent Nos. 5,843,660; 6,221,598; 6,479,235; and 7,008,771, which are owned by Promega Corp., are invalid under 35 U.S.C. § 112, first paragraph, for lack of enablement, and therefore reversed the District Court's denial of a motion…
-
By Cambria Alpha-Cobb* and Anthony D. Sabatelli** — If innovation drives progress, then 2014 was the year of progress! During the past year the U.S. Food and Drug Administration approved 41 new drugs. That is 14 more than 2013 and the highest number in 18 years! What spurred this increase? And what challenges do these…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Pfizer Inc. et al. v. Mylan Inc. et al.1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings…
-
January 13-14, 2015 – Advanced Summit on Life Sciences Patents (American Conference Institute) – New York, NY January 14-15, 2015 – "The USPTO Revised Patent Eligibility Guidance" (Intellectual Property Owners Association) – 2:00 to 3:15 pm (ET) January 15, 2015 – "Obviousness Standard After the AIA: Leveraging Latest PTO and Court Guidance — Overcoming Challenges…
-
The Intellectual Property Owners Association (IPO) will offer two webinars on "The USPTO Revised Patent Eligibility Guidance" on January 14 and 15, 2015 from 2:00 to 3:15 pm (ET) each day. The webinars will clarify the meaning of the new guidance, discuss which inventions are now more likely to be found patent eligible and how…
-
The Patent Litigation Committee of the Federal Circuit Bar Association (FCBA) will be holding a panel discussion webinar entitled "Have The Supreme Court's Octane and Highmark Decisions Obviated The Need For Legislative Changes to Section 285?" on January 15, 2015 from noon to 1:00 pm (ET). Eric C. Cohen of Katten Muchin Rosenman LLP will…
-
By Andrew Williams — For only the second time, the Patent Trial and Appeals Board ("PTAB" or "Board") granted a motion to amend claims. However, even though these two current motions were only granted-in-part, the fact that some claim amendments were accepted while others were denied can shed even more light on the Board's requirement…
-
By Donald Zuhn — After reflecting upon the events of the past twelve months, Patent Docs presents its eighth annual list oftop patent stories. For 2014, we identified eighteen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on patent practitioners and applicants. …
Patent Docs 